➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Harvard Business School
McKinsey
AstraZeneca
Baxter

Last Updated: October 23, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204654


Email this page to a colleague

« Back to Dashboard

NDA 204654 describes LO MINASTRIN FE, which is a drug marketed by Apil and is included in one NDA. There is one patent protecting this drug. Additional details are available on the LO MINASTRIN FE profile page.

The generic ingredient in LO MINASTRIN FE is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 204654
Tradename:LO MINASTRIN FE
Applicant:Apil
Ingredient:ethinyl estradiol; norethindrone acetate
Patents:1

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, CHEWABLE, TABLET;ORALStrength0.01MG,0.01MG,N/A;1MG,N/A,N/A
Approval Date:Jul 24, 2013TE:RLD:Yes
Patent:⤷  Try it FreePatent Expiration:Feb 2, 2029Product Flag?Substance Flag?Delist Request?
Patented Use:PREVENTION OF PREGNANCY

Expired US Patents for NDA 204654

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apil LO MINASTRIN FE ethinyl estradiol; norethindrone acetate TABLET, CHEWABLE, TABLET;ORAL 204654-001 Jul 24, 2013 ⤷  Try it Free ⤷  Try it Free
Apil LO MINASTRIN FE ethinyl estradiol; norethindrone acetate TABLET, CHEWABLE, TABLET;ORAL 204654-001 Jul 24, 2013 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Mallinckrodt
Express Scripts
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.